SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SI-BONE, Inc. (SIBN) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 21.95 M | 5.72 M | 61.05 M | 230.43 M | 211.39 M |
| 2022 | 20.67 M | 18.71 M | 59.25 M | 157.55 M | 137.61 M |
| 2021 | 14.25 M | -22,941,000 | 56.09 M | 190.51 M | 175.87 M |
| 2020 | 13.61 M | -14,126,000 | 53.78 M | 223.14 M | 218.24 M |
| 2019 | 11.72 M | 28.79 M | 54 M | 117.01 M | 111.46 M |